SEC Info - McClure Matthew W. - ‘4’ for 3/1/24 re: Aligos Therapeutics, Inc.

SEC Info℠

Home

Help

Please Sign In

McClure Matthew W. – ‘4’ for 3/1/24 re: Aligos Therapeutics, Inc.

On: Monday, 3/4/24, at 5:44pm ET · For: 3/1/24 · As: Officer · Accession #: 1610717-24-124 · File #: 1-39617

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/04/24  McClure Matthew W.                4          Officer     1:5K   Aligos Therapeutics, Inc.         Latham & Watk… Agent)/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      6K 
                Securities by an Insider -- form4.xml/5.8

Filing Submission 0001610717-24-000124 – SGML Text

Original SGML Text submitted by:	Latham & Watkins LLP (Filing Agent)/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

McClure Matthew W. – ‘4’ for 3/1/24 re: Aligos Therapeutics, Inc.

On: Monday, 3/4/24, at 5:44pm ET · For: 3/1/24 · As: Officer · Accession #: 1610717-24-124 · File #: 1-39617

Previous ‘4’: ‘4’ on 2/28/24 for 2/27/24 · Latest ‘4’: This Filing

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

To view the SGML, please refresh this page.

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents

To view the SGML, please refresh
this page.